1Bush K,Jacoby GA, Medeiros AA. A functional scheme for heta-lactamases and its correlation with molecular structure [J]. Antimicroh Agents Chemother, 1995,39(6) : 1211-1233.
2Jacoby GA. Epidemiology of extended-spectrum β-lactamases [J]. Clin Infect Dis,1998,27(1):81-83.
3Medeiros AA. Evolution and dissemination of beta-lactamases accelerated by generation of beta-lactam antibiotics[J]. Clin Infect Dis, 1997,24 (Suppl) : S19.
4Gniadkowski M. Evolution and epidemiology of extended-spectrum beta-lactamases ( ESBLs ) and ESBI.s-producing microorganisms [J]. Clin Microbiol Infect,2001,7(11):597-608.
5Livermore DM. Beta-lactamases in laboratory and clinical resistance[J]. Clin Microbiol Rev, 1995,8(4):557-584.
6Barthelemy M, Peduzzi J, Labia R. Distinction between the primary structures of TEM-1 and TEM-2 beta-lactamases[J]. Ann Inst Pasteur Microbiol, 1985,136:311-321.
7Bradford PA. Extended-spectrum beta-lactamases in the 21st Century:characterization, epidemiology,and detection of this important resistance threat[J]. Clin Microbiol Rev, 2001,14 (4):933-951.
8Sirot D,Recule C,Chaibi EB,et al. A complex mutant of TEM-1 beta-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate[J]. Antimicrob Agents Chemother, 1997,41 (6) : 1322- 1325.
9Matthew M,Hedges RW,Smith JT. Types of beta-lactamase determined by plasmids in Gram-negative bacteria[J]. J Bacteriol, 1979,138(3): 657-662.
10Tzouvelekis LS, Tzelepi E, Tassios PT,et al. CTX-M-type beta- lactamases: an emerging group of extended-spectrum enzymes[J]. Int J Antimicrob Agents, 2000,14(2) : 137-142.
